๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Resources for health care evaluation: Whither Australia?

โœ Scribed by Thomas P. Cloher


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
143 KB
Volume
1
Category
Article
ISSN
0749-6753

No coin nor oath required. For personal study only.

โœฆ Synopsis


In an era of accountability, no-one disputes anymore whether health care evaluation is a legitimate exercise. The hard questions are who is going to get it done and, above all, who is going to pay for it. Those questions were probably at the forefront of people's minds when attending a two-day workshop held in February 1985 in Canberra, Australia. The meeting was organized by the Australian National Health and Medical Research Council (NHMRC), which had brought together some 60 multidisciplinary professionals to review the situation in Australia-epidemiologists, economists, psychologists, medical and management scientists, and sociologists, inter alios. Some thirteen formal papers had been distributed beforehand; and issues raised by these texts were discussed in both plenary and syndicate sessions.

NHMRC has distributed funds on behalf of the Australian Federal Government since 1936. It both commissions specific research projects and grants fellowships to those it considers to be promising research professionals. Its record of achievement is indisputable, while its orientation has been heavily biomedical to the comparative detriment of social and economic research-and researchers. A break-down of all funding avenues for health and medical research in South Australia, for 1985, illustrates this point quite nicely: basic science, 55 per cent; clinical medicine and science, 30 per cent; preventive medicine and science, 5 per cent; health services research, 7 per cent. The major funding source was the NHMRC itself, and the categories nominated are the customary NHMRC ones (Hicks, 1985). Consequently, considerable energy was directed at the workshop towards supporting a resource shift that would bring more funding towards the social and economic end of the health and medical research spectrum.

It remains axiomatic, nonetheless, that shifting resources within a health (or education) system is almost an herculean exercise. In this case, however, momentum had already been provided by a Federal Budget allocation for 1984-85 to establish an Australian Institute of Health (AIH). This Bureau, within the Public Service, will report through the Director-General of Health; but, it has a mandate to initiate its own research programmes and publish its own results . Specifically, it will concern itself with research into the health status of the Australian population, and the provision and utilization of health services. It will have three divisions-Health Economics, Health Statistics, and Health Services-ostensibly designed to promote economic and social investigation of aspects of health system management.


๐Ÿ“œ SIMILAR VOLUMES


Whither trial-based economic evaluation
โœ Mark J. Sculpher; Karl Claxton; Mike Drummond; Chris McCabe ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 142 KB ๐Ÿ‘ 2 views

## Abstract The randomised controlled trial (RCT) has developed a central role in applied costโ€effectiveness studies in health care as the __vehicle__ for analysis. This paper considers the role of trialโ€based economic evaluation in this era of explicit decision making. It is argued that any framew

Access to health care resources in the U
โœ Carol Propper; Jenny Eachus; Philip Chan; Nicky Pearson; George Davey Smith ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 169 KB ๐Ÿ‘ 1 views

The paper uses new and detailed data from a population sample of individuals with arthritis to examine the impact of objective measures of need for treatment and individual measures of socio-economic position on the distribution of public and private health care. The quality of the data and the rang

Microworlds and generic structures as re
โœ Gary Hirsch; C. Sherry Immediato ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 205 KB

Decision-makers in the U.S. health care industry face three major changes: (1) a transition from a fee-for-service to a capitated payment system; (2) a shift from autonomous providers to integrated delivery of care; and (3) an expanded deยฎnition of health care to include health improvement and preve